March 2, 2021
|
Nurix Therapeutics Announces Launch of Proposed Public Offering of Common Stock
|
|
February 16, 2021
|
Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2020 Financial Results and Provides a Corporate Update
|
|
January 7, 2021
|
Nurix Therapeutics Announces Expansion of its Strategic Collaboration with Sanofi to Develop Novel Targeted Protein Degradation Therapies
|
|
January 5, 2021
|
Nurix Therapeutics Announces Presentation at 39th Annual J.P. Morgan Healthcare Conference
|
|